Establishment and effect evaluation of multidisciplinary diagnosis and treatment model of individualized treatment with elacycline

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500095429

Enrollment

Unknown

Registered

2025-01-07

Start date

2025-04-01

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial infection

Interventions

Observation group:none

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.From October 2024 to June 2027, he was hospitalized in Peking University First Hospital; 2.Age >18; 3.In the hospital, the application of clinical departments and the evaluation of multidisciplinary teams required the use of elacycline hydrochloride for injection; 4.Sign informed consent;

Exclusion criteria

Exclusion criteria: 1.Pregnant woman;

Design outcomes

Primary

Measure	Time frame
therapeutic drug monitoring;	—

Countries

China

Contacts

Public ContactZhou Ying

Peking University First Hospital

zhouying0321@126.com+86 10 66110802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026